# Lansoprazole

NDC: 0093-3008
Generic name: Lansoprazole
Labeler / Manufacturer: Teva Pharmaceuticals USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE
Routes: ORAL
Marketing started: 20180308

FDA application: ANDA208784

## Active ingredients

- LANSOPRAZOLE: 15 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0093-3008"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0093-3008
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6b8dd0e1-cd69-4f9a-887f-e42627b5d78e